Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Mutation Research|June 4, 2013
New DNA probes to detect aneugenicity in rat bone marrow micronucleated cells by a pan-centromeric FISH analysisAkira Takeiri, Shigeki Motoyama, Kaori Matsuzaki, et al.Mutation Research|August 19, 2006
A newly established GDL1 cell line from gpt delta mice well reflects the in vivo mutation spectra induced by mitomycin CAkira Takeiri, Masayuki Mishima, Kenji Tanaka, et al.Mutation Research|July 5, 2008
Two structurally distinct inhibitors of glycogen synthase kinase 3 induced centromere positive micronuclei in human lymphoblastoid TK6 cellsMasayuki Mishima, Kenji Tanaka, Akira Takeiri, et al.Journal of Applied Toxicology : JAT|May 20, 2025
Antitumor Cytotoxic Activity Retained in Tolerized T Cells Following Daily Dose Escalation of a T-Cell Engager in Cynomolgus Monkeys to Mitigate Cytokine Release SyndromeYoshika Iwata, Tomochika Matsushita, Yuta Narushima, et al.Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|May 23, 2018
Advantages of evaluating γH2AX induction in non-clinical drug developmentShigeki Motoyama, Akira Takeiri, Kenji Tanaka, et al.The Journal of Toxicological Sciences|July 2, 2023
Preclinical in vitro evaluation of immune suppression induced by GYM329, Fc-engineered sweeping antibodyYoshika Iwata, Hitoshi Katada, Momoko Okuda, et al.Toxicology and Applied Pharmacology|July 22, 2019
Daily ascending dosing in cynomolgus monkeys to mitigate cytokine release syndrome induced by ERY22, surrogate for T-cell redirecting bispecific antibody ERY974 for cancer immunotherapyYoshika Iwata, Masanori Sasaki, Asako Harada, et al.The Journal of Toxicological Sciences|July 20, 2016
Is an in vitro whole blood cytokine assay useful to detect the potential risk of severe infusion reaction of monoclonal antibody pharmaceuticals?Yoshika Iwata, Asako Harada, Toshiko Hara, et al.Science Translational Medicine|October 6, 2017
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumorsTakahiro Ishiguro, Yuji Sano, Shun-Ichiro Komatsu, et al.Pageof 2